Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery
Recruiting now · Not applicable
Conditions studied: Breast Cancer
In brief
The objective of this study is to compare two different doses of local anesthetics (10ml vs 20ml of 0.25% levobupivacaine) for subpectoral plexus block (SPPB) in addition to ultrasound guided multi-level of thoracic paravertebral block (m-TPVB) for surgical anaesthesia for major primary breast cancer surgery.
Key facts
- Study ID
- NCT04933266
- Run by
- Chinese University of Hong Kong
- People needed
- 100
- Starts
- 2024-03-15
- Expected to finish
- 2026-03-31
- Last updated by the study team
- 2025-04-11
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- scheduled for mastectomy, modified radical mastectomy or breast conservative surgery with lymph node biopsy and with or without axillary dissection
You may not qualify if…
- local skin site infection
- coagulopathy
- history of allergy to local anesthetics
Where it is running
- North District Hospital — Sheung Shui, New Territories, Hong Kong (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.